EXECUTIVE ENGAGEMENTS
OUTREACH
499
Number of executives repeatedly engaged by snail & email outreach
INTERACTIONS
102
Interactions with Platform & by Email
PARTICIPANTS
22
Unique # Participated
VALIDATIONS
8
Responses Validated*
COMPETITORS
29
Responses Validated*
* Login for a full stack data experience
DATE
APR 2021
TABLES
66
PAGES
125
EDITION
16
PRICE
USD $5450
*Engagement stats are ongoing and dynamic
HIGHLIGHTS
Amid the COVID-19 crisis, the global market for Cholesterol Testing estimated at US$12.4 Billion in the year 2020, is projected to reach a revised size of US$18.2 Billion by 2027, growing at a CAGR of 5.6% over the period 2020-2027.
The Cholesterol Testing market in the U.S. is estimated at US$3.4 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$3.8 Billion by the year 2027 trailing a CAGR of 8.6% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 3.1% and 5.1% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 3.5% CAGR.
SELECT PLAYERS
Abbott Laboratories; AccuTech LLC; Akers Biosciences Inc.; Beckman Coulter Inc.; Bio-Rad Laboratories Inc.; Boston Heart Diagnostics Corporation; Eurofins Scientific; F. Hoffmann-La Roche Ltd.; Home Access Health Corporation; Laboratory Corporation of America® Holdings; PTS Diagnostics; Quest Diagnostics Inc.; Randox Laboratories Ltd.; Sekisui Diagnostics LLC; Siemens Healthineers; Sigma-Aldrich Corp.
SEGMENTS
» Segment (Cholesterol Testing)
GEOGRAPHIES
» World » United States » Canada » Japan » China » Europe » France » Germany » Italy » United Kingdom » Spain » Russia » and Rest of Europe » Asia-Pacific » Australia » India » South Korea » and Rest of Asia-Pacific » Latin America » Argentina » Brazil » Mexico » and Rest of Latin America » Middle East » Iran » Israel » Saudi Arabia » United Arab Emirates » and Rest of Middle East » and Africa
TABLE OF CONTENTS
| I. METHODOLOGY |
| II. EXECUTIVE SUMMARY |
| 1. MARKET OVERVIEW |
| Influencer Market Insights |
| World Market Trajectories |
| Cholesterol Testing - An Overview |
| Recent Market Activity |
| Prevailing Scenario in the Global Healthcare Sector Favors Market Growth |
| Increasing Healthcare Expenditure |
| Wider Availability of Healthcare & Diagnostics Services |
| Growing Health-Consciousness |
| Lenience Towards Preventive Care |
| Developed Regions Remain Key Revenue Contributors |
| Developing Economies Offer Significant Potential |
| Key Factors Driving Demand for Healthcare Services in Developing Regions |
| Impact of Covid-19 and a Looming Global Recession |
| 2. FOCUS ON SELECT PLAYERS |
| Abbott Laboratories (USA) |
| AccuTech, LLC (USA) |
| Akers Biosciences, Inc. (USA) |
| Beckman Coulter, Inc. (USA) |
| Bio-Rad Laboratories, Inc. (USA) |
| Eurofins Scientific (Luxembourg) |
| Boston Heart Diagnostics Corporation (USA) |
| F. Hoffmann-La Roche Ltd. (Switzerland) |
| Home Access Health Corporation (USA) |
| Laboratory Corporation of America® Holdings (USA) |
| PRIMA Lab SA (Switzerland) |
| PTS Diagnostics (USA) |
| Quest Diagnostics, Inc. (USA) |
| Randox Laboratories Ltd. (UK) |
| Sekisui Diagnostics, LLC (USA) |
| Siemens Healthineers (Germany) |
| Sigma-Aldrich Corp. (USA) |
| 3. MARKET TRENDS & DRIVERS |
| Growing Prevalence of Cardiovascular Disease Steers Cholesterol Testing Volumes |
| Global Menace of Cardiovascular Disease: Quick Facts |
| A Brief Overview of Select Cholesterol-Driven Cardiac Disorders |
| Coronary Artery Disease |
| Hyperlipidaemia |
| CVD Statistics |
| Risk of CVD in Obese People Underpins Cholesterol Testing Volumes |
| Global Obesity Facts in a Nutshell |
| Cholesterol Screening Assumes Importance in Diabetes Care |
| Global Diabetes Expenditure: Opportunity Indicator |
| The Hypertension-Cholesterol Link Accelerates the Need for Cholesterol Screening |
| Aging Population - A Vital Demography |
| Uptrend in In-Vitro Diagnostics (IVD) Sector Signals Prospects |
| Healthy Growth in Cardiac IVD Market Augments Market Potential |
| Positive Momentum in Point of Care (POC) Diagnostics Generates Parallel Opportunities |
| POC Diagnostics - An Overview |
| POC Cholesterol Testing Makes Rapid Gains |
| Massive Demand for Lipid Panel/Lipid Profile Tests |
| Northbound Trajectory in POC LPT Services |
| Rise of C-reactive Protein Tests to Aid Market Growth |
| Cholesterol Testing: Evolution from Invasive to Non-Invasive |
| Recent Breakthroughs in Non-Invasive Cholesterol Testing Domain |
| Nonfasting Lipid Testing Invalidates the Need for Pre-Test Fasting |
| Cloud Screening Platforms Extend New Level of Convenience |
| Self-Testing Kits: An Emerging Issue for Full-Scale Services Providers |
| A Rapidly Evolving Market Enabled by Technology |
| Opportunities & Challenges in Self-Testing Industry |
| E-Retailing Drives Sales of Home Test Kits |
| A Brief Overview of Select Cholesterol Test Kits |
| 4. GLOBAL MARKET PERSPECTIVE |
| World Current & Future Analysis for Cholesterol Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World Historic Review for Cholesterol Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Cholesterol Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2012, 2020 & 2027 |
| III. MARKET ANALYSIS |
| UNITED STATES |
| USA Current & Future Analysis for Cholesterol Testing by Segment - Cholesterol Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| USA Historic Review for Cholesterol Testing by Segment - Cholesterol Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| CANADA |
| Canada Current & Future Analysis for Cholesterol Testing by Segment - Cholesterol Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Canada Historic Review for Cholesterol Testing by Segment - Cholesterol Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| JAPAN |
| Japan Current & Future Analysis for Cholesterol Testing by Segment - Cholesterol Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Japan Historic Review for Cholesterol Testing by Segment - Cholesterol Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| CHINA |
| China Current & Future Analysis for Cholesterol Testing by Segment - Cholesterol Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| China Historic Review for Cholesterol Testing by Segment - Cholesterol Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| EUROPE |
| Europe Current & Future Analysis for Cholesterol Testing by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| Europe Historic Review for Cholesterol Testing by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Europe 15-Year Perspective for Cholesterol Testing by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2012, 2020 & 2027 |
| FRANCE |
| France Current & Future Analysis for Cholesterol Testing by Segment - Cholesterol Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| France Historic Review for Cholesterol Testing by Segment - Cholesterol Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| GERMANY |
| Germany Current & Future Analysis for Cholesterol Testing by Segment - Cholesterol Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Germany Historic Review for Cholesterol Testing by Segment - Cholesterol Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| ITALY |
| Italy Current & Future Analysis for Cholesterol Testing by Segment - Cholesterol Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Italy Historic Review for Cholesterol Testing by Segment - Cholesterol Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| UNITED KINGDOM |
| UK Current & Future Analysis for Cholesterol Testing by Segment - Cholesterol Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| UK Historic Review for Cholesterol Testing by Segment - Cholesterol Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| SPAIN |
| Spain Current & Future Analysis for Cholesterol Testing by Segment - Cholesterol Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Spain Historic Review for Cholesterol Testing by Segment - Cholesterol Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| RUSSIA |
| Russia Current & Future Analysis for Cholesterol Testing by Segment - Cholesterol Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Russia Historic Review for Cholesterol Testing by Segment - Cholesterol Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| REST OF EUROPE |
| Rest of Europe Current & Future Analysis for Cholesterol Testing by Segment - Cholesterol Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Rest of Europe Historic Review for Cholesterol Testing by Segment - Cholesterol Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| ASIA-PACIFIC |
| Asia-Pacific Current & Future Analysis for Cholesterol Testing by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| Asia-Pacific Historic Review for Cholesterol Testing by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Asia-Pacific 15-Year Perspective for Cholesterol Testing by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2012, 2020 & 2027 |
| AUSTRALIA |
| Australia Current & Future Analysis for Cholesterol Testing by Segment - Cholesterol Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Australia Historic Review for Cholesterol Testing by Segment - Cholesterol Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| INDIA |
| India Current & Future Analysis for Cholesterol Testing by Segment - Cholesterol Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| India Historic Review for Cholesterol Testing by Segment - Cholesterol Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| SOUTH KOREA |
| South Korea Current & Future Analysis for Cholesterol Testing by Segment - Cholesterol Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| South Korea Historic Review for Cholesterol Testing by Segment - Cholesterol Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| REST OF ASIA-PACIFIC |
| Rest of Asia-Pacific Current & Future Analysis for Cholesterol Testing by Segment - Cholesterol Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Rest of Asia-Pacific Historic Review for Cholesterol Testing by Segment - Cholesterol Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| LATIN AMERICA |
| Latin America Current & Future Analysis for Cholesterol Testing by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| Latin America Historic Review for Cholesterol Testing by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Latin America 15-Year Perspective for Cholesterol Testing by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2012, 2020 & 2027 |
| ARGENTINA |
| Argentina Current & Future Analysis for Cholesterol Testing by Segment - Cholesterol Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Argentina Historic Review for Cholesterol Testing by Segment - Cholesterol Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| BRAZIL |
| Brazil Current & Future Analysis for Cholesterol Testing by Segment - Cholesterol Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Brazil Historic Review for Cholesterol Testing by Segment - Cholesterol Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| MEXICO |
| Mexico Current & Future Analysis for Cholesterol Testing by Segment - Cholesterol Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Mexico Historic Review for Cholesterol Testing by Segment - Cholesterol Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| REST OF LATIN AMERICA |
| Rest of Latin America Current & Future Analysis for Cholesterol Testing by Segment - Cholesterol Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Rest of Latin America Historic Review for Cholesterol Testing by Segment - Cholesterol Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| MIDDLE EAST |
| Middle East Current & Future Analysis for Cholesterol Testing by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| Middle East Historic Review for Cholesterol Testing by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Middle East 15-Year Perspective for Cholesterol Testing by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2012, 2020 & 2027 |
| IRAN |
| Iran Current & Future Analysis for Cholesterol Testing by Segment - Cholesterol Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Iran Historic Review for Cholesterol Testing by Segment - Cholesterol Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| ISRAEL |
| Israel Current & Future Analysis for Cholesterol Testing by Segment - Cholesterol Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Israel Historic Review for Cholesterol Testing by Segment - Cholesterol Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| SAUDI ARABIA |
| Saudi Arabia Current & Future Analysis for Cholesterol Testing by Segment - Cholesterol Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Saudi Arabia Historic Review for Cholesterol Testing by Segment - Cholesterol Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| UNITED ARAB EMIRATES |
| UAE Current & Future Analysis for Cholesterol Testing by Segment - Cholesterol Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| UAE Historic Review for Cholesterol Testing by Segment - Cholesterol Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| REST OF MIDDLE EAST |
| Rest of Middle East Current & Future Analysis for Cholesterol Testing by Segment - Cholesterol Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Rest of Middle East Historic Review for Cholesterol Testing by Segment - Cholesterol Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| AFRICA |
| Africa Current & Future Analysis for Cholesterol Testing by Segment - Cholesterol Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Africa Historic Review for Cholesterol Testing by Segment - Cholesterol Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| IV. COMPETITION |
| Total Companies Profiled: 29 |
Is the U.S. Still a Better Global Barometer than China?
PREVIEW REPORT
Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.
What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: Privacy@StrategyR.com